Trials / Completed
CompletedNCT04174625
The Effect of Omega 3 on 25 Hydroxyvitamin D
The Effect of Omega 3 Supplementations on Serum 25 Hydroxyvitamin D Levels
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Applied Science Private University · Academic / Other
- Sex
- All
- Age
- 22 Years – 66 Years
- Healthy volunteers
- Accepted
Summary
The effect of omega 3 fatty acid on serum 25-hydroxyvitamin D levels.
Detailed description
No data are available on the effect of omega 3 on serum 25-hydroxyvitamin D levels in Jordanian men and women. This study was designed to investigate whether omega 3 supplementation has a potential effect on the reducing of serum 25-hydroxyvitamin D levels. This randomized, placebo-controlled clinical trial (RCT) was designed to evaluate 300 mg omega-3FA daily for 2 months on serum levels of 25-hydroxyvitamin D levels. This RCT will be conducted on 80 to 90 Jordanian men and women aged 22 to 66 years. Baseline and follow-up levels for 25-hydroxyvitamin D (25OHD), parathyroid hormone (PTH), calcium, phosphate, liver and kidney functions will be assayed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Dietary Supplement: Omega3-FA | Dietary Supplement: Omega3-FA 300 mg of omega3-FA once daily for 8 weeks |
Timeline
- Start date
- 2020-11-25
- Primary completion
- 2021-07-17
- Completion
- 2021-12-15
- First posted
- 2019-11-22
- Last updated
- 2022-02-24
Locations
1 site across 1 country: Jordan
Source: ClinicalTrials.gov record NCT04174625. Inclusion in this directory is not an endorsement.